Figure 6. Five-year, non-compliance-censored, Kaplan-Meier graft survival rates for African-American (solid line) and non-African-American recipients of HCV-positive kidneys. At 5 years the graft survival rate among African-Americans was not different from that of non-African-Americans (63.5% vs. 74.3%, P = .98, log-rank).